Preclinical evidence of remote ischemic conditioning in ischemic stroke, a metanalysis update.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 12 2021
09 12 2021
Historique:
received:
30
06
2021
accepted:
12
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
1
2
2022
Statut:
epublish
Résumé
Remote ischemic conditioning (RIC) is a promising therapeutic approach for ischemic stroke patients. It has been proven that RIC reduces infarct size and improves functional outcomes. RIC can be applied either before ischemia (pre-conditioning; RIPreC), during ischemia (per-conditioning; RIPerC) or after ischemia (post-conditioning; RIPostC). Our aim was to systematically determine the efficacy of RIC in reducing infarct volumes and define the cellular pathways involved in preclinical animal models of ischemic stroke. A systematic search in three databases yielded 50 peer-review articles. Data were analyzed using random effects models and results expressed as percentage of reduction in infarct size (95% CI). A meta-regression was also performed to evaluate the effects of covariates on the pooled effect-size. 95.3% of analyzed experiments were carried out in rodents. Thirty-nine out of the 64 experiments studied RIPostC (61%), sixteen examined RIPreC (25%) and nine tested RIPerC (14%). In all studies, RIC was shown to reduce infarct volume (- 38.36%; CI - 42.09 to - 34.62%) when compared to controls. There was a significant interaction caused by species. Short cycles in mice significantly reduces infarct volume while in rats the opposite occurs. RIPreC was shown to be the most effective strategy in mice. The present meta-analysis suggests that RIC is more efficient in transient ischemia, using a smaller number of RIC cycles, applying larger length of limb occlusion, and employing barbiturates anesthetics. There is a preclinical evidence for RIC, it is safe and effective. However, the exact cellular pathways and underlying mechanisms are still not fully determined, and its definition will be crucial for the understanding of RIC mechanism of action.
Identifiants
pubmed: 34887465
doi: 10.1038/s41598-021-03003-6
pii: 10.1038/s41598-021-03003-6
pmc: PMC8660795
doi:
Substances chimiques
Anesthetics
0
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
23706Informations de copyright
© 2021. The Author(s).
Références
J Cereb Blood Flow Metab. 2021 Jan;41(1):3-13
pubmed: 32538284
Neural Regen Res. 2020 Jun;15(6):1033-1034
pubmed: 31823878
CNS Neurosci Ther. 2013 Dec;19(12):917-25
pubmed: 24267641
BMC Neurosci. 2015 Dec 29;16:97
pubmed: 26715469
Brain Res. 2012 Jun 12;1459:81-90
pubmed: 22560096
Brain Res. 2012 Mar 22;1445:92-102
pubmed: 22325092
Brain Res. 2009 Sep 8;1288:88-94
pubmed: 19631625
Transl Stroke Res. 2015 Jun;6(3):198-206
pubmed: 25744447
Indian J Exp Biol. 2014 Jun;52(6):597-605
pubmed: 24956890
Ann Clin Transl Neurol. 2018 Nov 15;6(1):186-196
pubmed: 30656197
N Engl J Med. 2015 Apr 2;372(14):1333-41
pubmed: 25830423
Neuroreport. 2019 Jun 12;30(9):664-670
pubmed: 30969244
Circulation. 1986 Nov;74(5):1124-36
pubmed: 3769170
BMC Neurol. 2020 Jul 2;20(1):266
pubmed: 32615939
Neurotherapeutics. 2012 Apr;9(2):371-9
pubmed: 22437447
J Cell Physiol. 2019 Aug;234(8):12637-12645
pubmed: 30536714
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Brain Circ. 2019 Jan-Mar;5(1):8-11
pubmed: 31001594
Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4866-71
pubmed: 26744879
Behav Brain Res. 2015 Aug 1;289:1-8
pubmed: 25907740
CNS Neurosci Ther. 2012 Dec;18(12):965-73
pubmed: 23191937
Transl Stroke Res. 2015 Feb;6(1):69-77
pubmed: 25351177
Cell Mol Neurobiol. 2019 Jul;39(5):671-686
pubmed: 31025223
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Ann Neurol. 2006 Mar;59(3):467-77
pubmed: 16453316
Biochem Biophys Res Commun. 2007 Aug 3;359(3):628-34
pubmed: 17548062
J Neuroinflammation. 2019 Sep 16;16(1):181
pubmed: 31526384
CNS Neurosci Ther. 2016 Jan;22(1):43-52
pubmed: 26384716
Cardiovasc Drugs Ther. 2010 Jun;24(3):235-54
pubmed: 20496105
Behav Brain Res. 2018 Mar 15;340:87-93
pubmed: 27780723
J Mol Neurosci. 2016 Apr;58(4):424-31
pubmed: 26852332
J Am Heart Assoc. 2018 Feb 24;7(5):
pubmed: 29478025
Neurol Res. 2015 May;37(5):447-53
pubmed: 25819636
Front Neurol. 2018 Feb 06;9:40
pubmed: 29467715
J Neuroinflammation. 2018 May 28;15(1):167
pubmed: 29807548
Neurochem Int. 2020 May;135:104690
pubmed: 31981607
J Neurosci. 2018 Jul 25;38(30):6722-6736
pubmed: 29946039
Int J Mol Med. 2014 Oct;34(4):957-66
pubmed: 25092271
J Neurol Sci. 2015 Oct 15;357(1-2):270-5
pubmed: 26282496
Clin Exp Pharmacol Physiol. 2017 Jun;44(6):656-663
pubmed: 28251683
Expert Opin Drug Discov. 2019 Mar;14(3):315-326
pubmed: 30714423
Neuroreport. 2016 May 4;27(7):469-75
pubmed: 27031871
Exp Ther Med. 2019 Sep;18(3):1953-1960
pubmed: 31410157
Neurochem Int. 2019 Oct;129:104461
pubmed: 31095978
CNS Neurosci Ther. 2018 Jun;24(6):519-527
pubmed: 29399973
Neural Regen Res. 2014 Aug 1;9(15):1460-3
pubmed: 25317158
Neurochem Res. 2014 Nov;39(11):2068-77
pubmed: 25082119
PLoS One. 2015 Nov 18;10(11):e0142021
pubmed: 26580958
Transl Stroke Res. 2014 Aug;5(4):484-90
pubmed: 24385308
J Cereb Blood Flow Metab. 2012 May;32(5):851-9
pubmed: 22274742
Neuroscience. 2008 Feb 19;151(4):1099-103
pubmed: 18201834
Stroke. 2011 Oct;42(10):2960-2
pubmed: 21836089
Brain Circ. 2020 Feb 18;6(1):11-18
pubmed: 32166195
Neurol Res. 2018 Mar;40(3):182-188
pubmed: 29369005
Stroke. 2012 Oct;43(10):2794-9
pubmed: 22910893
Neural Regen Res. 2018 Sep;13(9):1585-1593
pubmed: 30127119
Neurol Res. 2019 Jan;41(1):26-36
pubmed: 30281410
Neural Regen Res. 2012 Mar 15;7(8):583-7
pubmed: 25745448
Nat Rev Neurol. 2015 Dec;11(12):698-710
pubmed: 26585977
Neurosci Behav Physiol. 2005 Jul;35(6):567-72
pubmed: 16342612
J Cereb Blood Flow Metab. 2017 Aug;37(8):3001-3014
pubmed: 27909265
Aging Dis. 2015 Nov 17;6(6):406-17
pubmed: 26618042
Metab Brain Dis. 2017 Dec;32(6):1805-1818
pubmed: 28707040
Front Aging Neurosci. 2020 Mar 10;12:54
pubmed: 32210788
Biochemistry (Mosc). 2017 Sep;82(9):1006-1016
pubmed: 28988529
Nat Rev Cardiol. 2016 Apr;13(4):193-209
pubmed: 26843289
Aging Dis. 2018 Oct 1;9(5):869-879
pubmed: 30271664
Mol Neurodegener. 2011 Jan 25;6(1):11
pubmed: 21266064
Transl Stroke Res. 2021 Jun;12(3):461-473
pubmed: 33405011
Ann Clin Transl Neurol. 2019 Jan 15;6(2):310-323
pubmed: 30847363
Neurochem Res. 2013 Apr;38(4):815-25
pubmed: 23389659
Transl Stroke Res. 2013 Feb;4(1):19-24
pubmed: 24323188
Neuroreport. 2019 Aug 14;30(12):834-841
pubmed: 31283710
Int J Mol Sci. 2016 Nov 25;17(12):
pubmed: 27898007
PLoS One. 2020 Jan 16;15(1):e0227624
pubmed: 31945776
Int J Stroke. 2016 Oct;11(8):938-943
pubmed: 27412192
Neurology. 2020 Dec 15;95(24):e3355-e3363
pubmed: 33028663
Anesth Analg. 2011 Nov;113(5):1180-7
pubmed: 21865497
Neurobiol Dis. 2013 Jun;54:105-14
pubmed: 23454199
Int J Neurosci. 2016 Jun;126(6):552-559
pubmed: 26000916
Brain Circ. 2017 Oct-Dec;3(4):204-212
pubmed: 30276326
Transplantation. 2002 Nov 15;74(9):1247-51
pubmed: 12451261
Transl Stroke Res. 2014 Dec;5(6):692-700
pubmed: 25043802
Stroke. 2014 Jan;45(1):159-67
pubmed: 24203849